192 related articles for article (PubMed ID: 26033479)
1. Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance.
Yao Y; Xia D; Bian Y; Sun Y; Zhu F; Pan B; Niu M; Zhao K; Wu Q; Qiao J; Fu C; Li Z; Xu K
Apoptosis; 2015 Aug; 20(8):1122-33. PubMed ID: 26033479
[TBL] [Abstract][Full Text] [Related]
2. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion.
Wei W; Huang H; Zhao S; Liu W; Liu CX; Chen L; Li JM; Wu YL; Yan H
Apoptosis; 2013 Sep; 18(9):1060-70. PubMed ID: 23613107
[TBL] [Abstract][Full Text] [Related]
3. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
[TBL] [Abstract][Full Text] [Related]
4. Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression.
Yang C; Yang J; Sun M; Yan J; Meng X; Ma T
IUBMB Life; 2013 May; 65(5):435-44. PubMed ID: 23441067
[TBL] [Abstract][Full Text] [Related]
5. Alantolactone Induces Apoptosis and Cell Cycle Arrest on Lung Squamous Cancer SK-MES-1 Cells.
Zhao P; Pan Z; Luo Y; Zhang L; Li X; Zhang G; Zhang Y; Cui R; Sun M; Zhang X
J Biochem Mol Toxicol; 2015 May; 29(5):199-206. PubMed ID: 25597476
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Alantolactone on Proliferation of RPMI-8226 Cells and Its Possible Mechnism].
Yao Y; Sun YY; Xia DD; Niu MS; Zhao K; Li ZY; Zeng LY; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1336-40. PubMed ID: 26524033
[TBL] [Abstract][Full Text] [Related]
7. Alantolactone induces activation of apoptosis in human hepatoma cells.
Lei JC; Yu JQ; Yin Y; Liu YW; Zou GL
Food Chem Toxicol; 2012 Sep; 50(9):3313-9. PubMed ID: 22721982
[TBL] [Abstract][Full Text] [Related]
8. Alantolactone induces apoptosis in RKO cells through the generation of reactive oxygen species and the mitochondrial pathway.
Zhang Y; Bao YL; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
Mol Med Rep; 2013 Oct; 8(4):967-72. PubMed ID: 23970102
[TBL] [Abstract][Full Text] [Related]
9. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells.
Chun J; Choi RJ; Khan S; Lee DS; Kim YC; Nam YJ; Lee DU; Kim YS
Int Immunopharmacol; 2012 Dec; 14(4):375-83. PubMed ID: 22940184
[TBL] [Abstract][Full Text] [Related]
10. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
[TBL] [Abstract][Full Text] [Related]
11. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
Chun J; Li RJ; Cheng MS; Kim YS
Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
[TBL] [Abstract][Full Text] [Related]
12. PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance.
Azab F; Vali S; Abraham J; Potter N; Muz B; de la Puente P; Fiala M; Paasch J; Sultana Z; Tyagi A; Abbasi T; Vij R; Azab AK
Br J Haematol; 2014 Apr; 165(1):89-101. PubMed ID: 24405121
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway.
Cui L; Bu W; Song J; Feng L; Xu T; Liu D; Ding W; Wang J; Li C; Ma B; Luo Y; Jiang Z; Wang C; Chen J; Hou J; Yan H; Yang L; Jia X
Arch Pharm Res; 2018 Mar; 41(3):299-313. PubMed ID: 29214600
[TBL] [Abstract][Full Text] [Related]
14. The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells.
Chen G; Xu Z; Chang G; Hou J; Hu L; Zhang Y; Yu D; Li B; Chang S; Xie Y; Zhang Y; Wei R; Wu H; Xiao W; Sun X; Tao Y; Gao L; Dai B; Shi J; Zhu W
Oncol Rep; 2017 Jul; 38(1):488-496. PubMed ID: 28560392
[TBL] [Abstract][Full Text] [Related]
15. Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB.
He R; Shi X; Zhou M; Zhao Y; Pan S; Zhao C; Guo X; Wang M; Li X; Qin R
Toxicol Appl Pharmacol; 2018 Oct; 356():159-171. PubMed ID: 30086361
[TBL] [Abstract][Full Text] [Related]
16. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
Zheng H; Yang L; Kang Y; Chen M; Lin S; Xiang Y; Li C; Dai X; Huang X; Liang G; Zhao C
Mol Carcinog; 2019 Apr; 58(4):565-576. PubMed ID: 30520143
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of alantolactone on the proliferation of K562/ADR cells and its mechanism].
Yang C; Cai H; Yan J; Yang J; Sun M; Meng X; Ma T
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):515-8. PubMed ID: 24985175
[TBL] [Abstract][Full Text] [Related]
18. Alantolactone induces apoptosis and suppresses migration in MCF‑7 human breast cancer cells via the p38 MAPK, NF‑κB and Nrf2 signaling pathways.
Liu J; Liu M; Wang S; He Y; Huo Y; Yang Z; Cao X
Int J Mol Med; 2018 Oct; 42(4):1847-1856. PubMed ID: 30015828
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous targeting of PI3K and mTOR with NVP-BGT226 is highly effective in multiple myeloma.
Baumann P; Schneider L; Mandl-Weber S; Oduncu F; Schmidmaier R
Anticancer Drugs; 2012 Jan; 23(1):131-8. PubMed ID: 21959532
[TBL] [Abstract][Full Text] [Related]
20. Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells.
Kang X; Wang H; Li Y; Xiao Y; Zhao L; Zhang T; Zhou S; Zhou X; Li Y; Shou Z; Chen C; Li B
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1961-1970. PubMed ID: 31116036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
